LAIR1 and systemic lupus erythematosus: Although there are still gaps in our understanding of the functions of C1q in complex microenvironments, targeting LAIR-1 will enable the development of new therapeutic strategies for many diseases, including inflammation, SLE, tumors, and hopefully COVID-19.